BRIEF-Vanda Pharmaceuticals Reports Fourth Quarter And Full Year 2020 Financial Results
BRIEF-Vanda Pharmaceuticals Reports Fourth Quarter And Full Year 2020 Financial Results
* VANDA PHARMACEUTICALS REPORTS FOURTH QUARTER AND FULL YEAR 2020 FINANCIAL RESULTS
* VANDA PHARMACEUTICALS INC - Q4 2020 TOTAL REVENUES GREW TO $67.7 MILLION, AN 11% INCREASE COMPARED TO Q4 2019
* VANDA PHARMACEUTICALS INC - END OF YEAR 2021 CASH EXPECTED TO BE GREATER THAN $400 MILLION
* VANDA PHARMACEUTICALS INC SEES 2021 TOTAL REVENUES $270 TO $300 MILLION
* VANDA PHARMACEUTICALS INC QTRLY EARNINGS PER SHARE $0.15
Source text for Eikon: Further company coverage:
((Reuters.Briefs@thomsonreuters.com;)
Feb 10 (Reuters) - Vanda Pharmaceuticals Inc :
* VANDA PHARMACEUTICALS REPORTS FOURTH QUARTER AND FULL YEAR 2020 FINANCIAL RESULTS
* VANDA PHARMACEUTICALS INC - Q4 2020 TOTAL REVENUES GREW TO $67.7 MILLION, AN 11% INCREASE COMPARED TO Q4 2019
* VANDA PHARMACEUTICALS INC - END OF YEAR 2021 CASH EXPECTED TO BE GREATER THAN $400 MILLION
* VANDA PHARMACEUTICALS INC SEES 2021 TOTAL REVENUES $270 TO $300 MILLION
* VANDA PHARMACEUTICALS INC QTRLY EARNINGS PER SHARE $0.15
Source text for Eikon: Further company coverage:
((Reuters.Briefs@thomsonreuters.com;)
路透2月10日電-萬達製藥(Vanda PharmPharmticals Inc)：*Vanda PharmPharmticals報告2020年第四季度和全年財務業績*Vanda PharmPharmticals Inc-2020年第四季度總收入增長至6770萬美元，比2019年第四季度增長11%*Vanda PharmPharmticals Inc.-2021年底現金預計將超過4億美元*Vanda PharmPharmticals Inc.預計2021年總收入為2.7億至3億美元*Vanda PharmPharmticals Inc Qtrly每股收益0.15美元Eikon的源文本：進一步的公司報道：(Reurs.Briefs@thomsonreurs.com；)
譯文內容由第三人軟體翻譯。
風險及免責聲明
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能，分享給你的好友吧